Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaxCyte Share News (MXCT)

Share Price Information for MaxCyte (MXCT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 374.00
Ask: 386.00
Change: 0.00 (0.00%)
Spread: 12.00 (3.209%)
Open: 380.00
High: 380.00
Low: 380.00
Prev. Close: 380.00
MXCT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Wed, 03rd May 2023 14:50

Thursday 4 May 
Apax Global Alpha LtdQ1 Results
BAE Systems PLCTrading Statement
Cardiff Property PLCHalf Year Results
Derwent London PLCTrading Statement
e-Therapeutics PLCFull Year Results
Glanbia PLCQ1 Results
IMI PLCTrading Statement
Mondi PLCTrading Statement
Morgan Sindall Group PLCTrading Statement
Next PLCTrading Statement
Rathbones Group PLCTrading Statement
Shell PLCQ1 Results
Spirent Communications PLCTrading Statement
Trainline PLCFull Year Results
Virgin Wines UK PLCHalf Year Results
Wheaton Precious MetalsQ1 Results
Friday 5 May 
Eqtec PLCFull Year Results
InterContinental Hotels Group PLCTrading Statement
International Consolidated Airlines Group SAQ1 Results
Monday 8 May 
no events scheduled 
Tuesday 9 May 
Kosmos Energy LtdQ1 Results
Tialis Essential IT PLCFull Year Results
Treatt PLCHalf Year Results
Wednesday 10 May 
Anexo Group PLCFull Year Results
Asos PLCHalf Year Results
Compass Group PLCHalf Year Results
Directa Plus PLCFull Year Results
Georgia Capital PLCQ1 Results
MaxCyte IncQ1 Results
Spirax-Sarco Engineering PLCTrading Statement
Valeura Energy IncQ1 Results
Vertu Motors PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
30 Jul 2021 20:39

TRADING UPDATES: Cambria Automobiles suitor tables improved offer

TRADING UPDATES: Cambria Automobiles suitor tables improved offer

Read more
30 Jul 2021 12:25

MaxCyte announces pricing of upsized Nasdaq share offering

(Sharecast News) - Cell engineering technology company MaxCyte announced the pricing of its upsized offering of 13,500,000 shares on Nasdaq on Friday, at a price of $13.00 per share.

Read more
26 Jul 2021 20:23

TRADING UPDATES: Attraqt and tinyBuild trade in line in first half

TRADING UPDATES: Attraqt and tinyBuild trade in line in first half

Read more
19 Jul 2021 21:48

IN BRIEF: MaxCyte makes administrative changes ahead of Nasdaq listing

IN BRIEF: MaxCyte makes administrative changes ahead of Nasdaq listing

Read more
29 Jun 2021 15:53

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
15 Jun 2021 19:33

EXECUTIVE CHANGES: Keywords Studies CEO Day retires after 12 years

EXECUTIVE CHANGES: Keywords Studies CEO Day retires after 12 years

Read more
25 May 2021 19:40

TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry

TRADING UPDATES: Bank of Cyprus outlook hinges on tourism industry

Read more
25 May 2021 11:45

MaxCyte signs strategic partnership with Celularity

(Sharecast News) - Cell-based therapy developer MaxCyte announced the signing of a strategic platform licence with clinical-stage biotechnology company Celularity on Tuesday.

Read more
14 May 2021 14:13

IN BRIEF: MaxCyte prepares for listing in New York

IN BRIEF: MaxCyte prepares for listing in New York

Read more
14 May 2021 09:05

MaxCyte proposes dual listing on Nasdaq

(Sharecast News) - Cell engineering technology company MaxCyte has submitted a draft registration statement with the Securities and Exchange Commission (SEC), it announced on Friday, for a proposed dual-listing and public offering of shares on the Nasdaq market.

Read more
13 May 2021 19:16

IN BRIEF: MaxCyte to consolidate two lines of common stock into one

IN BRIEF: MaxCyte to consolidate two lines of common stock into one

Read more
13 May 2021 11:22

MaxCyte to consolidate two of its lines of shares

(Sharecast News) - Cell engineering company MaxCyte announced the consolidation of two of its lines of common stock into a single unrestricted line of common stock on Thursday.

Read more
20 Apr 2021 12:08

TRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss

TRADING UPDATES: Zegona profit sinks; Flowtech Fluidpower suffers loss

Read more
20 Apr 2021 09:22

MaxCyte reports good performance despite Covid challenges

(Sharecast News) - Cell engineering technology company MaxCyte reported a 21% year-on-year improvement in revenues in its final results on Tuesday, to $26.2m (£18.74m), despite the challenges of the Covid-19 pandemic.

Read more
4 Feb 2021 09:41

MaxCyte raises £40m from new and existing investors

(Sharecast News) - Cell engineering and life sciences company MaxCyte has announced a subscription to raise £40m, in a bid to strengthen its balance sheet.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.